Skip Navigation



Nucleic Acids Research Advance Access published online on August 16, 2006

Nucleic Acids Research, doi:10.1093/nar/gkl505
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1246K) Freely available
Right arrow Screen PDF (1246K) Freely available
Right arrowOA All Versions of this Article:
34/14/4000    most recent
gkl505v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Shivji, M. K. K.
Right arrow Articles by Venkitaraman, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shivji, M. K. K.
Right arrow Articles by Venkitaraman, A. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (
http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Molecular Biology

A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange

Mahmud K. K. Shivji, Owen R. Davies1, Jane M. Savill, Debbie L. Bates, Luca Pellegrini1 and Ashok R. Venkitaraman*

Cancer Research UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, University of Cambridge Hills Road, Cambridge CB2 2XZ, UK 1 Department of Biochemistry, University of Cambridge Tennis Court Road, Cambridge CB2 1GA, UK

*To whom correspondence should be addressed. Ashok R. Venkitaraman, Hutchison/MRC Research Centre, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK. Tel: +44 1223 336901; Fax: +44 1223 763374; Email: arv22{at}cam.ac.uk

Received May 2, 2006. Revised June 28, 2006. Accepted July 3, 2006.

Human BRCA2, a breast and ovarian cancer suppressor, binds to the DNA recombinase RAD51 through eight conserved BRC repeats, motifs of ~30 residues, dispersed across a large region of the protein. BRCA2 is essential for homologous recombination in vivo, but isolated BRC repeat peptides can prevent the assembly of RAD51 into active nucleoprotein filaments in vitro, suggesting a model in which BRCA2 sequesters RAD51 in undamaged cells, and promotes recombinase function after DNA damage. How BRCA2 might fulfill these dual functions is unclear. We have purified a fragment of human BRCA2 (BRCA2BRC1–8) with 1127 residues spanning all 8 BRC repeats but excluding the C-terminal DNA-binding domain (BRCA2CTD). BRCA2BRC1–8 binds RAD51 nucleoprotein filaments in a ternary complex, indicating it may organize RAD51 on DNA. Human RAD51 is relatively ineffective in vitro at strand exchange between homologous DNA molecules unless non-physiological ions like Formula are present. In an ionic milieu more typical of the mammalian nucleus, BRCA2BRCI–8 stimulates RAD51-mediated strand exchange, suggesting it may be an essential co-factor in vivo. Thus, the human BRC repeats, embedded within their surronding sequences as an eight-repeat unit, mediate homologous recombination independent of the BRCA2CTD through a previously unrecognized role in control of RAD51 activity.


The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
B. Evers, R. Drost, E. Schut, M. de Bruin, E. van der Burg, P. W.B. Derksen, H. Holstege, X. Liu, E. van Drunen, H. B. Beverloo, et al.
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
Clin. Cancer Res., June 15, 2008; 14(12): 3916 - 3925.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Mazloum, Q. Zhou, and W. K. Holloman
D-loop formation by Brh2 protein of Ustilago maydis
PNAS, January 15, 2008; 105(2): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Adimoolam, M. Sirisawad, J. Chen, P. Thiemann, J. M. Ford, and J. J. Buggy
HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination
PNAS, December 4, 2007; 104(49): 19482 - 19487.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. I. R. Petalcorin, V. E. Galkin, X. Yu, E. H. Egelman, and S. J. Boulton
Stabilization of RAD-51-DNA filaments via an interaction domain in Caenorhabditis elegans BRCA2
PNAS, May 15, 2007; 104(20): 8299 - 8304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Q. Zhou, M. Kojic, Z. Cao, M. Lisby, N. A. Mazloum, and W. K. Holloman
Dss1 Interaction with Brh2 as a Regulatory Mechanism for Recombinational Repair
Mol. Cell. Biol., April 1, 2007; 27(7): 2512 - 2526.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.